Prescription drug · UNAPPROVED DRUG OTHER
Urelle NDC 0037-6321
Hyoscyamine sulfate .12 mg/1 + 4 more ingredients · Tablet · Oral · Viatris Specialty LLC
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 0037-6321-90 | 00037632190 | 90 TABLET in 1 BOTTLE (0037-6321-90)Marketed from Jan 12, 2015 |
How the 11-digit form is made: The labeler segment has 4 digits, so one leading zero is added to it (4-4-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Urelle
- Generic name (nonproprietary)
- hyoscyamine sulfate, methenamine, methylene blue, phenyl salicylate, and sodium phosphate, monobasic, monohydrate
- Active ingredients
- Hyoscyamine sulfate — .12 mg/1Methenamine — 81 mg/1Methylene blue — 10.8 mg/1Phenyl salicylate — 32.4 mg/1Sodium phosphate, Monobasic, Monohydrate — 40.8 mg/1
- Dosage form
- Tablet
- Route
- Oral
- Labeler
- Viatris Specialty LLC
- Product type
- Prescription drug
- Marketing category
- Unapproved drug (other)
- Marketing start
- Listing expires
- Other FDA classes
- Oxidation-Reduction Activity (Mechanism)
- Identifiers
- Product ID 0037-6321_a8f8f4f1-ad2a-40af-9089-764a459fb8fdSPL ID a8f8f4f1-ad2a-40af-9089-764a459fb8fdSPL set ID 1d80a11c-6f86-403b-85d4-32ec1924dbe9RxCUI 1048336, 1048340UNII F2R8V82B84, J50OIX95QV, T42P99266K, 28A37T47QO, 593YOG76RN
- Pharmacologic class
- Oxidation-Reduction Agent
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.
- NDC on a medical claim
N400037632190followed by a unit qualifier and the quantityPackage 00037-6321-90. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective .
Indications (excerpt from the label)
INDICATIONS and USAGE: Urelle ® is indicated for the treatment of symptoms of irritative voiding. Indicated for the relief of local symptoms, such as inflammation, hypermotility, and pain, which accompany lower urinary tract infections. Indicated for the relief of urinary tract symptoms caused by diagnostic procedures.
Excerpt only. Read the full label for complete information.